{"gene":"RAPGEF2","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1999,"finding":"PDZ-GEF1 (RAPGEF2) is a guanine nucleotide exchange factor that activates both Rap1 and Rap2 in vitro and in vivo. It contains a domain related to cAMP-binding domains that acts as a negative regulatory domain, but unlike Epac, PDZ-GEF1 does not bind cAMP or cGMP.","method":"In vitro GEF assay, in vivo Rap1 activation assay, domain mutagenesis/deletion analysis, cAMP/cGMP binding assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of GEF activity, domain functional analysis, replicated across multiple assays in a focused mechanistic study","pmids":["10608883"],"is_preprint":false},{"year":2001,"finding":"RA-GEF-2 (RAPGEF2) stimulates guanine nucleotide exchange on Rap1 and Rap2 but not Ha-Ras. Its RA domain binds GTP-loaded M-Ras specifically (not other Ras family GTPases), recruiting RAPGEF2 to the plasma membrane where it activates Rap1 downstream of M-Ras.","method":"In vitro GEF assay, GST pulldown for RA domain binding specificity, co-localization in COS-7 cells, Rap1-GTP pulldown assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro GEF assay plus binding specificity panel plus cellular co-localization, single lab but multiple orthogonal methods","pmids":["11524421"],"is_preprint":false},{"year":2001,"finding":"The RA domain of RA-GEF-1 (RAPGEF2) mediates binding to GTP-Rap1 and is required for translocation to the perinuclear/Golgi compartment, where it amplifies Rap1 activation in vivo and enhances B-Raf activation. Deletion of the RA domain abolishes in vivo but not in vitro GEF activity, revealing a positive feedback mechanism.","method":"RA domain deletion mutagenesis, Rap1 pulldown assay, B-Raf activation assay, subcellular co-localization with anti-TGN38 antibody in COS-7 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — domain mutagenesis with in vitro and in vivo GEF assays plus localization, multiple orthogonal methods in one study","pmids":["11359771"],"is_preprint":false},{"year":2007,"finding":"PDZ-GEF1 (RAPGEF2) forms a tetrameric complex with synaptic scaffolding molecule (S-SCAM) and ARMS/Kidins220, which interacts directly with the TrkA neurotrophin receptor. Upon NGF binding and TrkA internalization to late endosomes, this complex induces sustained Rap1 and ERK activation leading to neurite outgrowth. PDZ-GEF1 is activated by GTP-Rap1 via a positive feedback mechanism at late endosomes.","method":"Co-immunoprecipitation, pulldown assays, subcellular fractionation/localization (endosome markers), live imaging, siRNA knockdown with neurite outgrowth readout","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, localization with functional consequence (neurite outgrowth), loss-of-function with specific readout, multiple orthogonal methods in one study","pmids":["17724123"],"is_preprint":false},{"year":2007,"finding":"RA-GEF-2 (RAPGEF2) mediates TNF-α-induced integrin (LFA-1) activation in splenocytes via an M-Ras→RA-GEF-2→Rap1 pathway. TNF-α activates M-Ras and Rap1 at the plasma membrane with concomitant recruitment of RA-GEF-2; knockdown or genetic knockout of RA-GEF-2 abolishes this Rap1 activation and LFA-1-mediated cell aggregation.","method":"siRNA knockdown in BAF3 cells, RA-GEF-2 knockout mice, Rap1-GTP pulldown, cell aggregation assay, subcellular fractionation","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout confirmed in primary cells plus siRNA knockdown in cell lines, multiple orthogonal methods, pathway epistasis established","pmids":["17538012"],"is_preprint":false},{"year":2007,"finding":"RA-GEF-1/RAPGEF2 knockout mice exhibit mid-gestation lethality (~E9.5) associated with severe defects in yolk sac blood vessel formation (failure of blood islands to coalesce into a vascular plexus), establishing an in vivo role in vascular morphogenesis.","method":"Conventional knockout mouse, embryo morphology analysis, histology","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic KO with defined vascular phenotype, single lab","pmids":["17826737"],"is_preprint":false},{"year":2009,"finding":"RA-GEF-1/RAPGEF2 is required for Rap1 activation and VE-cadherin accumulation at endothelial cell-cell junctions during vascular plexus formation; constitutively active Rap1 rescues the vascular defects caused by RA-GEF-1 knockout, placing RA-GEF-1 upstream of Rap1 in vascular network formation.","method":"In vitro allantois explant culture, endothelial cell culture, Rap1 activation probe, VE-cadherin immunostaining, rescue with constitutively active Rap1","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis by Rap1 rescue, Rap1 activation measurement, and functional vascular assay in same study","pmids":["19635461"],"is_preprint":false},{"year":2009,"finding":"Conditional knockout of RA-GEF-1/RAPGEF2 in the dorsal telencephalon (Emx1-Cre) causes subcortical band heterotopia-like ectopic cortical mass, agenesis of commissures (corpus callosum, anterior commissure), and lowered seizure threshold, establishing a required role in cortical neuronal migration.","method":"Conditional knockout mice (Emx1-Cre), brain histology, retrograde tracing, EEG seizure threshold measurement","journal":"The European journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — tissue-specific genetic KO with defined structural and functional neurological phenotypes, single lab","pmids":["19453629"],"is_preprint":false},{"year":2010,"finding":"RapGEF2 conditional knockout mice die at ~E11.5 with yolk sac vascular defects and defective embryonic hematopoiesis. RapGEF2-null hematopoietic progenitors show impaired Rap1 activation, reduced B-Raf/ERK signaling, and decreased Scl/Gata transcription factor expression. Adult inducible deletion has no impact on hematopoiesis.","method":"Conditional knockout mice, flow cytometry (CD41, Flk1), colony formation assay, Rap1-GTP pulldown, Western blot for ERK/B-Raf signaling, RT-PCR for Scl/Gata","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple orthogonal molecular readouts (Rap1 activation, ERK signaling, transcription factor expression), single lab","pmids":["20595512"],"is_preprint":false},{"year":2013,"finding":"Rapgef2 connects GPCR-mediated cAMP elevation to ERK activation via a Rap1→B-Raf→MEK pathway in neuroendocrine/neuronal cells, and is required for cAMP-dependent neuritogenesis. Rapgef2 is specifically eluted by cAMP from cAMP-agarose, indicating direct cAMP binding or interaction.","method":"cAMP-agarose affinity chromatography, siRNA knockdown (loss-of-function in NS-1 cells), gain-of-function in HEK293T cells, Western blot for ERK/B-Raf/MEK phosphorylation, neurite outgrowth assay","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 / Moderate — biochemical enrichment by cAMP affinity plus reciprocal loss/gain-of-function with defined ERK/neuritogenesis readouts, multiple methods in one study","pmids":["23800469"],"is_preprint":false},{"year":2013,"finding":"JAM-A associates directly with ZO-2 and indirectly with afadin, forming a complex with PDZ-GEF1 that activates Rap2c to regulate epithelial tight junction barrier function and apical actomyosin contraction. siRNA knockdown of PDZ-GEF1 phenocopies JAM-A loss with enhanced paracellular permeability.","method":"Co-immunoprecipitation, siRNA knockdown, paracellular permeability assay, RhoA/myosin phosphorylation western blot","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP establishing complex, siRNA functional validation with defined permeability phenotype, multiple methods","pmids":["23885123"],"is_preprint":false},{"year":2013,"finding":"RAPGEF2 is phosphorylated by IKKβ and CK1α in response to pro-migratory factors, leading to proteasomal degradation via the SCF(βTrCP) ubiquitin ligase. Failure to degrade RAPGEF2 sustains Rap1 activity and inhibits HGF-induced cell migration and breast cancer metastasis.","method":"In vivo phosphorylation assay, kinase inhibitor studies, ubiquitin ligase genetic manipulation, degradation-resistant RAPGEF2 mutant expression, Rap1-GTP pulldown, cell migration assay, in vivo metastasis assay","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — identified writer kinases (IKKβ, CK1α) and E3 ligase (SCF-βTrCP), with phospho-mutant functional rescue and in vivo metastasis validation, multiple orthogonal methods","pmids":["24290981"],"is_preprint":false},{"year":2014,"finding":"RapGEF2 is phosphorylated by Cdk5, and this phosphorylation is required for RapGEF2-mediated Rap1 activation and N-cadherin upregulation during the multipolar-to-bipolar transition of cortical neurons. In utero electroporation knockdown of RapGEF2 blocks this polarity transition and radial migration.","method":"In utero electroporation, live imaging, Cdk5 kinase assay, Rap1-GTP pulldown, N-cadherin immunostaining, dominant-negative/constitutively active constructs","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — identified Cdk5 as the upstream kinase with functional epistasis through Rap1/N-cadherin pathway, loss-of-function with live imaging, multiple orthogonal methods","pmids":["25189171"],"is_preprint":false},{"year":2016,"finding":"Rapgef2 (and Rapgef6) act cell-autonomously through Rap1 to maintain apical adherens junctions in radial glia. Double knockout of Rapgef2 and Rapgef6 disrupts apical AJ structures, detaches radial glial cells, and disorganizes the radial glial fiber system; constitutively active Rap1(G12V) rescues the AJ disruption, placing Rapgef2/6 upstream of Rap1 in this pathway.","method":"Conditional knockout mice, intrauterine Cre electroporation, constitutively active Rap1 rescue, immunostaining for AJ markers (β-catenin, N-cadherin), cortical layer analysis","journal":"eNeuro","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis confirmed by Rap1 rescue, double KO phenotypic analysis, cell-autonomous mechanism established by electroporation","pmids":["27390776"],"is_preprint":false},{"year":2017,"finding":"NCS-Rapgef2 contains a cyclic nucleotide-binding domain (CNBD) that is required for cAMP-dependent ERK activation; mutation of a conserved CNBD residue abrogates cAMP-ERK coupling, whereas deletion of the CNBD results in constitutive ERK activation. NCS-Rapgef2 is encoded from an alternative first exon (exon 1') and is selectively expressed in neuronal and endocrine tissues.","method":"CNBD point mutagenesis and deletion mutagenesis, reconstitution in HEK293T cells, cAMP-ERK phosphorylation assay, tissue-specific mRNA and protein expression analysis, Rapgef2 CamK2α-Cre conditional KO mice, D1 receptor agonist ERK assay","journal":"eNeuro","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — active site mutagenesis plus conditional genetic KO plus reconstitution in non-expressing cells, replicated across multiple systems","pmids":["28948210"],"is_preprint":false},{"year":2017,"finding":"The cAMP-binding pharmacophore of NCS-Rapgef2 is distinct from those of PKA and Epac. N6-Phe-cAMP is a selective NCS-Rapgef2 agonist, and N6-phenyl-9-tetrahydrofuranyladenine is a selective NCS-Rapgef2 inhibitor without activity at PKA, Epac, or adenylate cyclase.","method":"Cell-based pharmacological assay (high-content microscopy for ERK/PKA-II activation), EC50/IC50 determination for adenine derivatives across cAMP effectors in NS-1 neuroendocrine cells","journal":"ACS chemical neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based selectivity profiling with quantitative dose-response, single lab, no in vitro binding confirmation","pmids":["28290664"],"is_preprint":false},{"year":2019,"finding":"RAPGEF2 forms a complex with MAGI2, and this interaction is lost when MAGI2 carries congenital nephrotic syndrome (CNS) variants. Co-expression of RapGEF2 with wild-type but not mutant MAGI2 enhances Rap1 activation in podocytes. Podocyte-specific RapGEF2 deletion in mice causes spontaneous glomerulosclerosis comparable to MAGI2 KO.","method":"Co-immunoprecipitation (MAGI2-RapGEF2 complex), Rap1-GTP pulldown, podocyte-specific conditional KO mice, siRNA knockdown in human podocytes, pharmacological Rap1 activation rescue","journal":"Kidney international","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, conditional KO phenotype, Rap1 activation measurement, rescue by Rap1 agonist, multiple orthogonal methods","pmids":["31171376"],"is_preprint":false},{"year":2020,"finding":"NCS-Rapgef2 in nucleus accumbens D1-medium spiny neurons mediates cocaine-induced ERK phosphorylation and Egr-1/Zif268 upregulation via a D1 receptor→cAMP→NCS-Rapgef2→Rap1→B-Raf→MEK→ERK pathway. AAV-Cre-mediated NCS-Rapgef2 deletion in NAc eliminates cocaine-induced locomotor sensitization and conditioned place preference without affecting PKA/CREB phosphorylation.","method":"AAV-Synapsin-Cre injection for region-specific gene deletion, CamK2α-Cre conditional KO, pERK and Egr-1 immunostaining, cocaine behavioral tests (locomotor sensitization, CPP), ex vivo slice electrophysiology","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — region-specific genetic ablation with molecular (pERK, Egr-1) and behavioral readouts, pathway dissection from PKA/CREB, multiple brain regions and methods","pmids":["33268547"],"is_preprint":false},{"year":2020,"finding":"In sensory neurons, cAMP-to-ERK signaling involves RapGEF2 (and PKA) but not Epac; Oncostatin M (OSM) priming enhances and prolongs this RapGEF2/PKA-dependent cAMP-ERK coupling in IB4/CaMKIIα-positive nociceptors.","method":"High-content microscopy for endogenous PKA-II and ERK activation, selective pharmacological inhibition of Rapgef2/Epac/PKA, OSM priming paradigm in primary sensory neuron cultures","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway dissection with quantitative single-cell readouts, single lab","pmids":["32885411"],"is_preprint":false},{"year":2021,"finding":"RAPGEF2 upregulation mediates oligomeric Aβ-induced synaptic loss via activation of downstream Rap2 and JNK. siRNA silencing of RAPGEF2 blocks Aβ oligomer-induced dendritic spine loss in hippocampal neurons, and in vivo knockdown prevents cognitive deficits and excitatory synapse loss in 3xTg-AD mice.","method":"siRNA knockdown in primary hippocampal neurons, in vivo AAV-shRNA knockdown in 3xTg-AD mice, dendritic spine counting, Rap2/JNK activation western blot, behavioral testing (cognitive function), electron microscopy of synapses","journal":"Neuropathology and applied neurobiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with defined molecular pathway (Rap2/JNK) and behavioral/synaptic readouts, multiple orthogonal methods","pmids":["33345400"],"is_preprint":false},{"year":2021,"finding":"GLP-1 receptor stimulation activates ERK via NCS-RapGEF2 in pancreatic beta cells (INS-1) and NS-1 neuroendocrine cells; shRNA-mediated RapGEF2 knockdown reduces exendin-4-induced ERK phosphorylation, establishing NCS-RapGEF2 as a component of the GLP-1R→cAMP→ERK pathway.","method":"shRNA knockdown, pERK western blot, MEK inhibitor (U0126), transduction of GLP1R into NS-1 cells, neurite outgrowth assay, transcriptome analysis of INS-1 cells","journal":"Journal of neuroendocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined ERK readout, MEK dependency confirmed, single lab","pmids":["33960038"],"is_preprint":false},{"year":2024,"finding":"RapGEF2 is required for cAMP-dependent ERK activation and Egr1 (but not c-Fos) induction in hippocampal CA1/dentate gyrus during fear conditioning, and for cAMP-dependent long-term potentiation at perforant pathway and Schaffer collateral synapses. Context-dependent fear memory is impaired by hippocampal RapGEF2 ablation.","method":"CamK2α-Cre conditional KO mice, pERK and Egr1 immunostaining after fear conditioning, LTP recording in hippocampal slices ex vivo, behavioral fear conditioning assay","journal":"Cellular and molecular life sciences","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with molecular (pERK, Egr1), electrophysiological (LTP), and behavioral readouts, multiple orthogonal methods, gene-specific cre line","pmids":["38236296"],"is_preprint":false},{"year":2026,"finding":"RAPGEF2 operates downstream of the G13 (GNA13)-coupled receptors (αIIbβ3 integrin, thromboxane receptor) in platelets to activate RAP1 and mediate integrin αIIbβ3-dependent platelet adhesion under shear stress. Megakaryocyte-specific RAPGEF2 knockout reduces RAP1 activation and integrin activation, especially under elevated shear stress conditions.","method":"Megakaryocyte-specific conditional KO mice (Rapgef2mKO), double KO with CalDAG-GEFI, RAP1-GTP pulldown, platelet aggregation assay, microfluidic adhesion under shear stress, flow cytometry for integrin activation","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO (single and double with CalDAG-GEFI) plus multiple platelet functional assays and RAP1 activation measurement, pathway epistasis established","pmids":["41949994"],"is_preprint":false}],"current_model":"RAPGEF2 (PDZ-GEF1/NCS-Rapgef2/RA-GEF-2) is a ubiquitously expressed but neuronal/endocrine-enriched (NCS isoform) guanine nucleotide exchange factor that directly activates Rap1 and Rap2 GTPases; it is regulated by a cAMP-binding domain (acting as a negative regulator that cAMP can relieve), a positive-feedback RA domain that binds GTP-Rap1, upstream kinases (Cdk5 and IKKβ/CK1α—the latter targeting RAPGEF2 for SCF-βTrCP-mediated proteasomal degradation), and recruitment by activated M-Ras or scaffold complexes (S-SCAM/ARMS with TrkA at late endosomes; MAGI2 in podocytes; JAM-A/ZO-2/afadin at tight junctions; G13-coupled receptors in platelets); activated RAPGEF2 drives Rap1→B-Raf→MEK→ERK signaling underlying neurite outgrowth, neuronal migration (multipolar-bipolar transition via N-cadherin), synaptic plasticity and fear memory (ERK/Egr1), cocaine-induced behavioral sensitization, epithelial barrier maintenance, vascular morphogenesis, embryonic hematopoiesis, podocyte cytoskeletal integrity, and platelet adhesion."},"narrative":{"mechanistic_narrative":"RAPGEF2 (PDZ-GEF1/RA-GEF-2/NCS-Rapgef2) is a guanine nucleotide exchange factor that directly catalyzes nucleotide exchange on the small GTPases Rap1 and Rap2 — but not Ras — converting diverse upstream signals into Rap-dependent control of cell adhesion, junction integrity, migration, and ERK-driven gene expression [PMID:10608883, PMID:11524421]. Its catalytic output is tuned by intramolecular and recruitment-based regulation: a cyclic nucleotide-binding domain that, unlike Epac, couples cAMP to activation rather than acting as a classical cAMP sensor, while a Ras-association (RA) domain binds GTP-Rap1 to drive a positive-feedback loop and binds GTP-loaded M-Ras to recruit the enzyme to membranes and amplify Rap1 activation at the plasma membrane and perinuclear/Golgi compartment [PMID:11359771, PMID:11524421, PMID:28948210]. A neuronal/endocrine-enriched isoform, NCS-Rapgef2, arises from an alternative first exon and links GPCR-driven cAMP elevation to a Rap1→B-Raf→MEK→ERK cascade in neurons and endocrine cells, where mutation of a conserved CNBD residue uncouples cAMP from ERK while CNBD deletion renders the enzyme constitutively active [PMID:23800469, PMID:28948210]. Through this Rap1-ERK axis NCS-Rapgef2 mediates cAMP-dependent neuritogenesis, fear-memory-associated Egr1 induction and hippocampal LTP, and cocaine-induced behavioral sensitization downstream of D1 receptors [PMID:23800469, PMID:38236296, PMID:33268547]. RAPGEF2 is also assembled into membrane and junctional scaffolds — an S-SCAM/ARMS complex with the TrkA receptor at late endosomes that sustains NGF-induced Rap1/ERK signaling and neurite outgrowth, a JAM-A/ZO-2/afadin complex regulating epithelial tight-junction barrier function via Rap2, and a MAGI2 complex in podocytes maintaining glomerular integrity [PMID:17724123, PMID:23885123, PMID:31171376]. Genetic studies establish broad in vivo roles in yolk-sac vascular morphogenesis and embryonic hematopoiesis, cortical neuronal migration and adherens-junction maintenance in radial glia, podocyte integrity, and G13-coupled integrin activation in platelets, all converging on Rap1 as confirmed by constitutively active Rap1 rescue [PMID:17826737, PMID:20595512, PMID:19453629, PMID:27390776, PMID:31171376, PMID:41949994]. RAPGEF2 stability is controlled by IKKβ/CK1α phosphorylation triggering SCF-βTrCP-mediated proteasomal degradation, which limits Rap1 activity to permit cell migration [PMID:24290981].","teleology":[{"year":1999,"claim":"Established RAPGEF2's core catalytic identity — that it is a GEF selective for Rap1 and Rap2 carrying a cAMP-binding-like domain that, unlike Epac, does not bind cyclic nucleotides.","evidence":"In vitro and in vivo GEF assays with domain deletion mutagenesis and cAMP/cGMP binding tests","pmids":["10608883"],"confidence":"High","gaps":["How the cAMP-binding-like domain regulates activity if it does not bind cAMP was unresolved","No upstream activating signal identified at this stage"]},{"year":2001,"claim":"Defined the RA domain as a dual regulatory module — binding GTP-M-Ras to recruit RAPGEF2 to the plasma membrane and binding GTP-Rap1 to create a positive-feedback amplification loop at perinuclear/Golgi membranes.","evidence":"GST pulldown binding-specificity panels, RA-domain deletion, Rap1/B-Raf activation assays and co-localization in COS-7 cells","pmids":["11524421","11359771"],"confidence":"High","gaps":["Physiological receptors triggering M-Ras activation not defined","In vivo significance of the feedback loop not yet tested"]},{"year":2007,"claim":"Connected RAPGEF2 to receptor signaling and immune adhesion by placing it in a TrkA/S-SCAM/ARMS late-endosomal complex for NGF-induced neurite outgrowth and in an M-Ras→Rap1 pathway for TNF-α-induced LFA-1 activation.","evidence":"Reciprocal Co-IP, endosomal fractionation and live imaging with neurite readout; siRNA and knockout-mouse splenocyte aggregation assays","pmids":["17724123","17538012"],"confidence":"High","gaps":["Stoichiometry and assembly order of the tetrameric TrkA complex not resolved","Whether the same recruitment logic applies across cell types not addressed"]},{"year":2007,"claim":"Demonstrated an essential developmental requirement by showing RAPGEF2 knockout causes mid-gestation lethality with failed yolk-sac vascular plexus formation.","evidence":"Conventional knockout mice with embryo morphology and histology","pmids":["17826737"],"confidence":"Medium","gaps":["Molecular effector linking RAPGEF2 loss to vascular failure not yet defined","Single-lab observation"]},{"year":2009,"claim":"Placed RAPGEF2 mechanistically upstream of Rap1 in vascular morphogenesis, showing it is needed for VE-cadherin junctional accumulation and that constitutively active Rap1 rescues the defect.","evidence":"Allantois explant culture, Rap1 activation probe, VE-cadherin staining and CA-Rap1 rescue","pmids":["19635461"],"confidence":"High","gaps":["Receptor input driving RAPGEF2 in endothelium not identified","How Rap1 controls VE-cadherin localization not detailed"]},{"year":2009,"claim":"Revealed a CNS requirement, showing dorsal-telencephalon RAPGEF2 deletion causes cortical migration defects (band heterotopia), commissural agenesis, and lowered seizure threshold.","evidence":"Emx1-Cre conditional knockout with histology, retrograde tracing and EEG seizure measurement","pmids":["19453629"],"confidence":"High","gaps":["Cellular mechanism of the migration defect not resolved at this stage","Downstream Rap1 effectors in neurons not yet defined"]},{"year":2010,"claim":"Defined RAPGEF2's role in embryonic hematopoiesis, linking its loss to impaired Rap1/B-Raf/ERK signaling and reduced Scl/Gata transcription factor expression, while showing adult hematopoiesis is independent.","evidence":"Conditional knockout mice, flow cytometry, colony assays, Rap1-GTP pulldown, ERK/B-Raf Western and RT-PCR","pmids":["20595512"],"confidence":"High","gaps":["Direct link between ERK signaling and Scl/Gata transcription not mechanistically dissected","Why the requirement is embryo-restricted is unexplained"]},{"year":2013,"claim":"Established the long-sought cAMP-to-ERK function — that Rapgef2 couples GPCR cAMP elevation to Rap1→B-Raf→MEK→ERK and is directly enriched by cAMP affinity, plus defined its roles in tight-junction barrier function (via Rap2/JAM-A/ZO-2/afadin) and as a degradation target of IKKβ/CK1α/SCF-βTrCP controlling migration.","evidence":"cAMP-agarose affinity chromatography with loss/gain-of-function ERK readouts; reciprocal Co-IP with permeability assays; phospho-mutant rescue with metastasis assay","pmids":["23800469","23885123","24290981"],"confidence":"High","gaps":["Whether cAMP binds RAPGEF2 directly or via a partner was not structurally resolved","Phospho-degron site geometry on RAPGEF2 not mapped"]},{"year":2014,"claim":"Identified Cdk5 as an upstream activating kinase, showing its phosphorylation of RapGEF2 is required for Rap1-driven N-cadherin upregulation in the cortical multipolar-to-bipolar transition.","evidence":"In utero electroporation, live imaging, Cdk5 kinase assay, Rap1 pulldown and N-cadherin staining","pmids":["25189171"],"confidence":"High","gaps":["Cdk5 phosphosite(s) on RapGEF2 not mapped","Mechanism linking Rap1 to N-cadherin transcription/trafficking not defined"]},{"year":2016,"claim":"Showed RapGEF2 (with Rapgef6) maintains apical adherens junctions in radial glia cell-autonomously through Rap1, confirmed by CA-Rap1 rescue of the double-knockout phenotype.","evidence":"Conditional double knockout, Cre electroporation, CA-Rap1 rescue and adherens-junction marker immunostaining","pmids":["27390776"],"confidence":"High","gaps":["Functional redundancy boundaries between RAPGEF2 and RAPGEF6 not delineated","Effector connecting Rap1 to AJ stability not identified"]},{"year":2017,"claim":"Resolved the structural basis of cAMP coupling, defining the NCS-Rapgef2 CNBD as required for cAMP-dependent ERK activation and identifying the tissue-restricted exon-1' isoform plus a distinct cAMP pharmacophore with selective agonists/inhibitors.","evidence":"CNBD point and deletion mutagenesis with reconstitution and conditional KO; cell-based pharmacological selectivity profiling of adenine derivatives","pmids":["28948210","28290664"],"confidence":"High","gaps":["Direct in vitro cAMP binding to the CNBD not biochemically confirmed","Structural mechanism of how CNBD occupancy relieves autoinhibition not solved"]},{"year":2019,"claim":"Tied RAPGEF2 to podocyte biology and disease, showing it forms a Rap1-activating complex with MAGI2 disrupted by congenital nephrotic syndrome variants, with podocyte-specific deletion causing glomerulosclerosis.","evidence":"Co-IP, Rap1-GTP pulldown, podocyte conditional KO, siRNA in human podocytes and Rap1-agonist rescue","pmids":["31171376"],"confidence":"High","gaps":["Whether RAPGEF2 mutations themselves cause human nephrotic syndrome not established","Cytoskeletal effector downstream of podocyte Rap1 not defined"]},{"year":2020,"claim":"Established NCS-Rapgef2 as the cAMP-ERK node for reward and nociceptive signaling, mediating D1-receptor-driven cocaine sensitization (independent of PKA/CREB) and OSM-primed sensory-neuron cAMP-ERK coupling.","evidence":"Region-specific AAV-Cre ablation with pERK/Egr-1 readouts and cocaine behavioral assays; pharmacological pathway dissection in sensory neurons","pmids":["33268547","32885411"],"confidence":"High","gaps":["How NCS-Rapgef2-ERK signaling drives synaptic plasticity changes underlying sensitization not fully detailed","Sensory-neuron data rest on pharmacology, not genetics"]},{"year":2021,"claim":"Broadened the disease and endocrine relevance of RAPGEF2, implicating it in Aβ-induced synaptic loss via Rap2/JNK and in GLP-1 receptor→ERK signaling in beta cells.","evidence":"siRNA and in vivo AAV-shRNA knockdown in 3xTg-AD mice with spine/behavior readouts; shRNA knockdown with pERK and MEK-inhibitor analysis in INS-1/NS-1 cells","pmids":["33345400","33960038"],"confidence":"High","gaps":["How Aβ upregulates RAPGEF2 mechanistically not defined","Switch between Rap1-ERK and Rap2-JNK output not explained"]},{"year":2024,"claim":"Demonstrated RapGEF2's role in hippocampal memory, showing it is required for cAMP-dependent ERK/Egr1 induction and LTP during fear conditioning, with selectivity for Egr1 over c-Fos.","evidence":"CamK2α-Cre conditional KO with pERK/Egr1 immunostaining, ex vivo LTP recording and fear-conditioning behavior","pmids":["38236296"],"confidence":"High","gaps":["Basis of the Egr1-versus-c-Fos selectivity not resolved","Synaptic locus of RapGEF2 action not pinpointed"]},{"year":2026,"claim":"Extended RAPGEF2 function to hemostasis, placing it downstream of G13-coupled receptors to drive Rap1 and integrin αIIbβ3 activation for shear-dependent platelet adhesion, distinct from CalDAG-GEFI.","evidence":"Megakaryocyte-specific KO and double KO with CalDAG-GEFI, RAP1 pulldown, microfluidic shear adhesion and flow cytometry","pmids":["41949994"],"confidence":"High","gaps":["Direct link between G13/GNA13 and RAPGEF2 recruitment not biochemically resolved","How shear stress selectively engages the RAPGEF2 arm not defined"]},{"year":null,"claim":"How a single GEF integrates its multiple regulatory inputs (cAMP/CNBD, RA-domain feedback, Cdk5 and IKKβ/CK1α phosphorylation, scaffold recruitment) into context-specific Rap1 versus Rap2 output remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model integrating CNBD, RA-domain and catalytic GEF domains","Determinants selecting Rap1-ERK versus Rap2-JNK signaling unknown","Whether cAMP binds the CNBD directly not biochemically confirmed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[3,10,16]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,4]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[2]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,14,17]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,7,8,13]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,17,21]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[22]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[10,16]}],"complexes":["S-SCAM/ARMS/TrkA complex","JAM-A/ZO-2/afadin complex"],"partners":["RAP1","RAP2","MRAS","TRKA","MAGI2","JAMA","CDK5","GNA13"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y4G8","full_name":"Rap guanine nucleotide exchange factor 2","aliases":["Cyclic nucleotide ras GEF","CNrasGEF","Neural RAP guanine nucleotide exchange protein","nRap GEP","PDZ domain-containing guanine nucleotide exchange factor 1","PDZ-GEF1","RA-GEF-1","Ras/Rap1-associating GEF-1"],"length_aa":1499,"mass_kda":167.4,"function":"Functions as a guanine nucleotide exchange factor (GEF), which activates Rap and Ras family of small GTPases by exchanging bound GDP for free GTP in a cAMP-dependent manner. Serves as a link between cell surface receptors and Rap/Ras GTPases in intracellular signaling cascades. Also acts as an effector for Rap1 by direct association with Rap1-GTP thereby leading to the amplification of Rap1-mediated signaling. Shows weak activity on HRAS. It is controversial whether RAPGEF2 binds cAMP and cGMP (PubMed:23800469, PubMed:10801446) or not (PubMed:10548487, PubMed:10608844, PubMed:11359771). Its binding to ligand-activated beta-1 adrenergic receptor ADRB1 leads to the Ras activation through the G(s)-alpha signaling pathway. Involved in the cAMP-induced Ras and Erk1/2 signaling pathway that leads to sustained inhibition of long term melanogenesis by reducing dendrite extension and melanin synthesis. Also provides inhibitory signals for cell proliferation of melanoma cells and promotes their apoptosis in a cAMP-independent nanner. Regulates cAMP-induced neuritogenesis by mediating the Rap1/B-Raf/ERK signaling through a pathway that is independent on both PKA and RAPGEF3/RAPGEF4. Involved in neuron migration and in the formation of the major forebrain fiber connections forming the corpus callosum, the anterior commissure and the hippocampal commissure during brain development. Involved in neuronal growth factor (NGF)-induced sustained activation of Rap1 at late endosomes and in brain-derived neurotrophic factor (BDNF)-induced axon outgrowth of hippocampal neurons. Plays a role in the regulation of embryonic blood vessel formation and in the establishment of basal junction integrity and endothelial barrier function. May be involved in the regulation of the vascular endothelial growth factor receptor KDR and cadherin CDH5 expression at allantois endothelial cell-cell junctions","subcellular_location":"Cytoplasm; Cytoplasm, perinuclear region; Cell membrane; Late endosome; Cell junction","url":"https://www.uniprot.org/uniprotkb/Q9Y4G8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RAPGEF2","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RAPGEF2","total_profiled":1310},"omim":[{"mim_id":"618075","title":"EPILEPSY, FAMILIAL ADULT MYOCLONIC, 7; FAME7","url":"https://www.omim.org/entry/618075"},{"mim_id":"618073","title":"STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 12; SAMD12","url":"https://www.omim.org/entry/618073"},{"mim_id":"614531","title":"RASGEF DOMAIN FAMILY, MEMBER 1A; RASGEF1A","url":"https://www.omim.org/entry/614531"},{"mim_id":"610499","title":"RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6","url":"https://www.omim.org/entry/610499"},{"mim_id":"609530","title":"RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; RAPGEF2","url":"https://www.omim.org/entry/609530"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RAPGEF2"},"hgnc":{"alias_symbol":["PDZ-GEF1","RA-GEF","DKFZP586O1422","KIAA0313"],"prev_symbol":["PDZGEF1"]},"alphafold":{"accession":"Q9Y4G8","domains":[{"cath_id":"2.60.120.10","chopping":"104-248","consensus_level":"medium","plddt":85.7783,"start":104,"end":248},{"cath_id":"3.10.20.90","chopping":"609-709","consensus_level":"high","plddt":87.6682,"start":609,"end":709},{"cath_id":"1.10.840.10","chopping":"714-884_964-998","consensus_level":"high","plddt":90.6119,"start":714,"end":998}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y4G8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y4G8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y4G8-F1-predicted_aligned_error_v6.png","plddt_mean":59.53},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RAPGEF2","jax_strain_url":"https://www.jax.org/strain/search?query=RAPGEF2"},"sequence":{"accession":"Q9Y4G8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y4G8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y4G8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y4G8"}},"corpus_meta":[{"pmid":"10608883","id":"PMC_10608883","title":"PDZ-GEF1, a guanine nucleotide exchange factor specific for Rap1 and Rap2.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10608883","citation_count":108,"is_preprint":false},{"pmid":"23885123","id":"PMC_23885123","title":"JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function.","date":"2013","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/23885123","citation_count":103,"is_preprint":false},{"pmid":"17724123","id":"PMC_17724123","title":"Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes, leading to sustained activation of Rap1 and ERK and neurite outgrowth.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17724123","citation_count":97,"is_preprint":false},{"pmid":"11524421","id":"PMC_11524421","title":"Identification and characterization of RA-GEF-2, a Rap guanine nucleotide exchange factor that serves as a downstream target of M-Ras.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11524421","citation_count":80,"is_preprint":false},{"pmid":"25189171","id":"PMC_25189171","title":"Cdk5-mediated phosphorylation of RapGEF2 controls neuronal migration in the developing cerebral cortex.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25189171","citation_count":68,"is_preprint":false},{"pmid":"22422452","id":"PMC_22422452","title":"DNA methylation shows genome-wide association of NFIX, RAPGEF2 and MSRB3 with gestational age at birth.","date":"2012","source":"International journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/22422452","citation_count":60,"is_preprint":false},{"pmid":"23800469","id":"PMC_23800469","title":"Rapgef2 connects GPCR-mediated cAMP signals to ERK activation in neuronal and endocrine cells.","date":"2013","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/23800469","citation_count":53,"is_preprint":false},{"pmid":"11359771","id":"PMC_11359771","title":"RA-GEF-1, a guanine nucleotide exchange factor for Rap1, is activated by translocation induced by association with Rap1*GTP and enhances Rap1-dependent B-Raf activation.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11359771","citation_count":52,"is_preprint":false},{"pmid":"17538012","id":"PMC_17538012","title":"The M-Ras-RA-GEF-2-Rap1 pathway mediates tumor necrosis factor-alpha dependent regulation of integrin activation in splenocytes.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17538012","citation_count":44,"is_preprint":false},{"pmid":"19453629","id":"PMC_19453629","title":"Dorsal telencephalon-specific RA-GEF-1 knockout mice develop heterotopic cortical mass and commissural fiber defect.","date":"2009","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19453629","citation_count":36,"is_preprint":false},{"pmid":"24290981","id":"PMC_24290981","title":"Control of epithelial cell migration and invasion by the IKKβ- and CK1α-mediated degradation of RAPGEF2.","date":"2013","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/24290981","citation_count":34,"is_preprint":false},{"pmid":"20595512","id":"PMC_20595512","title":"RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20595512","citation_count":31,"is_preprint":false},{"pmid":"28948210","id":"PMC_28948210","title":"NCS-Rapgef2, the Protein Product of the Neuronal Rapgef2 Gene, Is a Specific Activator of D1 Dopamine Receptor-Dependent ERK Phosphorylation in Mouse Brain.","date":"2017","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/28948210","citation_count":25,"is_preprint":false},{"pmid":"27390776","id":"PMC_27390776","title":"Crucial Role of Rapgef2 and Rapgef6, a Family of Guanine Nucleotide Exchange Factors for Rap1 Small GTPase, in Formation of Apical Surface Adherens Junctions and Neural Progenitor Development in the Mouse Cerebral Cortex.","date":"2016","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/27390776","citation_count":25,"is_preprint":false},{"pmid":"17826737","id":"PMC_17826737","title":"Defective vascular morphogenesis and mid-gestation embryonic death in mice lacking RA-GEF-1.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17826737","citation_count":23,"is_preprint":false},{"pmid":"31171376","id":"PMC_31171376","title":"Disruption of MAGI2-RapGEF2-Rap1 signaling contributes to podocyte dysfunction in congenital nephrotic syndrome caused by mutations in MAGI2.","date":"2019","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/31171376","citation_count":22,"is_preprint":false},{"pmid":"33268547","id":"PMC_33268547","title":"Cocaine-Dependent Acquisition of Locomotor Sensitization and Conditioned Place Preference Requires D1 Dopaminergic Signaling through a Cyclic AMP, NCS-Rapgef2, ERK, and Egr-1/Zif268 Pathway.","date":"2020","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33268547","citation_count":21,"is_preprint":false},{"pmid":"32885411","id":"PMC_32885411","title":"Oncostatin M induces hyperalgesic priming and amplifies signaling of cAMP to ERK by RapGEF2 and PKA.","date":"2020","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32885411","citation_count":20,"is_preprint":false},{"pmid":"33345400","id":"PMC_33345400","title":"RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.","date":"2021","source":"Neuropathology and applied neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/33345400","citation_count":18,"is_preprint":false},{"pmid":"24491570","id":"PMC_24491570","title":"Critical function of RA-GEF-2/Rapgef6, a guanine nucleotide exchange factor for Rap1, in mouse spermatogenesis.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24491570","citation_count":13,"is_preprint":false},{"pmid":"19635461","id":"PMC_19635461","title":"Impaired vascular development in the yolk sac and allantois in mice lacking RA-GEF-1.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19635461","citation_count":12,"is_preprint":false},{"pmid":"30636905","id":"PMC_30636905","title":"A De Novo RAPGEF2 Variant Identified in a Sporadic Amyotrophic Lateral Sclerosis Patient Impairs Microtubule Stability and Axonal Mitochondria Distribution.","date":"2018","source":"Experimental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/30636905","citation_count":12,"is_preprint":false},{"pmid":"28290664","id":"PMC_28290664","title":"Differential Pharmacophore Definition of the cAMP Binding Sites of Neuritogenic cAMP Sensor-Rapgef2, Protein Kinase A, and Exchange Protein Activated by cAMP in Neuroendocrine Cells Using an Adenine-Based Scaffold.","date":"2017","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28290664","citation_count":8,"is_preprint":false},{"pmid":"38236296","id":"PMC_38236296","title":"The guanine nucleotide exchange factor RapGEF2 is required for ERK-dependent immediate-early gene (Egr1) activation during fear memory formation.","date":"2024","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/38236296","citation_count":7,"is_preprint":false},{"pmid":"33960038","id":"PMC_33960038","title":"Cyclic AMP-dependent activation of ERK via GLP-1 receptor signalling requires the neuroendocrine cell-specific guanine nucleotide exchanger NCS-RapGEF2.","date":"2021","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/33960038","citation_count":5,"is_preprint":false},{"pmid":"16757323","id":"PMC_16757323","title":"Biochemistry of the Rap-specific guanine nucleotide exchange factors PDZ-GEF1 and -2.","date":"2006","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16757323","citation_count":1,"is_preprint":false},{"pmid":"30406181","id":"PMC_30406181","title":"Correction: Jiang et al., NCS-Rapgef2, the Protein Product of the Neuronal Rapgef2 Gene, Is a Specific Activator of D1 Dopamine Receptor-Dependent ERK Phosphorylation in Mouse Brain (eNeuro September/October 2017, 4(5) e0248-17.2017 1-17 https://doi.org/10.1523/ENEURO.0248-17.2017).","date":"2018","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/30406181","citation_count":1,"is_preprint":false},{"pmid":"41556274","id":"PMC_41556274","title":"Rare heterozygous de novo variants in RAPGEF2 are associated with a neurodevelopmental disorder.","date":"2026","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41556274","citation_count":0,"is_preprint":false},{"pmid":"41949994","id":"PMC_41949994","title":"A Novel G13-RAPGEF2-RAP1 Signaling Pathway Critical for Platelet Adhesion.","date":"2026","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/41949994","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.08.19.608697","title":"Removal of developmentally regulated microexons has a minimal impact on larval zebrafish brain morphology and function","date":"2024-08-20","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.19.608697","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18195,"output_tokens":6611,"usd":0.076875,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15471,"output_tokens":5979,"usd":0.113415,"stage2_stop_reason":"end_turn"},"total_usd":0.19029,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"PDZ-GEF1 (RAPGEF2) is a guanine nucleotide exchange factor that activates both Rap1 and Rap2 in vitro and in vivo. It contains a domain related to cAMP-binding domains that acts as a negative regulatory domain, but unlike Epac, PDZ-GEF1 does not bind cAMP or cGMP.\",\n      \"method\": \"In vitro GEF assay, in vivo Rap1 activation assay, domain mutagenesis/deletion analysis, cAMP/cGMP binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of GEF activity, domain functional analysis, replicated across multiple assays in a focused mechanistic study\",\n      \"pmids\": [\"10608883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RA-GEF-2 (RAPGEF2) stimulates guanine nucleotide exchange on Rap1 and Rap2 but not Ha-Ras. Its RA domain binds GTP-loaded M-Ras specifically (not other Ras family GTPases), recruiting RAPGEF2 to the plasma membrane where it activates Rap1 downstream of M-Ras.\",\n      \"method\": \"In vitro GEF assay, GST pulldown for RA domain binding specificity, co-localization in COS-7 cells, Rap1-GTP pulldown assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro GEF assay plus binding specificity panel plus cellular co-localization, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"11524421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The RA domain of RA-GEF-1 (RAPGEF2) mediates binding to GTP-Rap1 and is required for translocation to the perinuclear/Golgi compartment, where it amplifies Rap1 activation in vivo and enhances B-Raf activation. Deletion of the RA domain abolishes in vivo but not in vitro GEF activity, revealing a positive feedback mechanism.\",\n      \"method\": \"RA domain deletion mutagenesis, Rap1 pulldown assay, B-Raf activation assay, subcellular co-localization with anti-TGN38 antibody in COS-7 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — domain mutagenesis with in vitro and in vivo GEF assays plus localization, multiple orthogonal methods in one study\",\n      \"pmids\": [\"11359771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PDZ-GEF1 (RAPGEF2) forms a tetrameric complex with synaptic scaffolding molecule (S-SCAM) and ARMS/Kidins220, which interacts directly with the TrkA neurotrophin receptor. Upon NGF binding and TrkA internalization to late endosomes, this complex induces sustained Rap1 and ERK activation leading to neurite outgrowth. PDZ-GEF1 is activated by GTP-Rap1 via a positive feedback mechanism at late endosomes.\",\n      \"method\": \"Co-immunoprecipitation, pulldown assays, subcellular fractionation/localization (endosome markers), live imaging, siRNA knockdown with neurite outgrowth readout\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, localization with functional consequence (neurite outgrowth), loss-of-function with specific readout, multiple orthogonal methods in one study\",\n      \"pmids\": [\"17724123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RA-GEF-2 (RAPGEF2) mediates TNF-α-induced integrin (LFA-1) activation in splenocytes via an M-Ras→RA-GEF-2→Rap1 pathway. TNF-α activates M-Ras and Rap1 at the plasma membrane with concomitant recruitment of RA-GEF-2; knockdown or genetic knockout of RA-GEF-2 abolishes this Rap1 activation and LFA-1-mediated cell aggregation.\",\n      \"method\": \"siRNA knockdown in BAF3 cells, RA-GEF-2 knockout mice, Rap1-GTP pulldown, cell aggregation assay, subcellular fractionation\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout confirmed in primary cells plus siRNA knockdown in cell lines, multiple orthogonal methods, pathway epistasis established\",\n      \"pmids\": [\"17538012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RA-GEF-1/RAPGEF2 knockout mice exhibit mid-gestation lethality (~E9.5) associated with severe defects in yolk sac blood vessel formation (failure of blood islands to coalesce into a vascular plexus), establishing an in vivo role in vascular morphogenesis.\",\n      \"method\": \"Conventional knockout mouse, embryo morphology analysis, histology\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO with defined vascular phenotype, single lab\",\n      \"pmids\": [\"17826737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RA-GEF-1/RAPGEF2 is required for Rap1 activation and VE-cadherin accumulation at endothelial cell-cell junctions during vascular plexus formation; constitutively active Rap1 rescues the vascular defects caused by RA-GEF-1 knockout, placing RA-GEF-1 upstream of Rap1 in vascular network formation.\",\n      \"method\": \"In vitro allantois explant culture, endothelial cell culture, Rap1 activation probe, VE-cadherin immunostaining, rescue with constitutively active Rap1\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis by Rap1 rescue, Rap1 activation measurement, and functional vascular assay in same study\",\n      \"pmids\": [\"19635461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Conditional knockout of RA-GEF-1/RAPGEF2 in the dorsal telencephalon (Emx1-Cre) causes subcortical band heterotopia-like ectopic cortical mass, agenesis of commissures (corpus callosum, anterior commissure), and lowered seizure threshold, establishing a required role in cortical neuronal migration.\",\n      \"method\": \"Conditional knockout mice (Emx1-Cre), brain histology, retrograde tracing, EEG seizure threshold measurement\",\n      \"journal\": \"The European journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific genetic KO with defined structural and functional neurological phenotypes, single lab\",\n      \"pmids\": [\"19453629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RapGEF2 conditional knockout mice die at ~E11.5 with yolk sac vascular defects and defective embryonic hematopoiesis. RapGEF2-null hematopoietic progenitors show impaired Rap1 activation, reduced B-Raf/ERK signaling, and decreased Scl/Gata transcription factor expression. Adult inducible deletion has no impact on hematopoiesis.\",\n      \"method\": \"Conditional knockout mice, flow cytometry (CD41, Flk1), colony formation assay, Rap1-GTP pulldown, Western blot for ERK/B-Raf signaling, RT-PCR for Scl/Gata\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple orthogonal molecular readouts (Rap1 activation, ERK signaling, transcription factor expression), single lab\",\n      \"pmids\": [\"20595512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Rapgef2 connects GPCR-mediated cAMP elevation to ERK activation via a Rap1→B-Raf→MEK pathway in neuroendocrine/neuronal cells, and is required for cAMP-dependent neuritogenesis. Rapgef2 is specifically eluted by cAMP from cAMP-agarose, indicating direct cAMP binding or interaction.\",\n      \"method\": \"cAMP-agarose affinity chromatography, siRNA knockdown (loss-of-function in NS-1 cells), gain-of-function in HEK293T cells, Western blot for ERK/B-Raf/MEK phosphorylation, neurite outgrowth assay\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical enrichment by cAMP affinity plus reciprocal loss/gain-of-function with defined ERK/neuritogenesis readouts, multiple methods in one study\",\n      \"pmids\": [\"23800469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"JAM-A associates directly with ZO-2 and indirectly with afadin, forming a complex with PDZ-GEF1 that activates Rap2c to regulate epithelial tight junction barrier function and apical actomyosin contraction. siRNA knockdown of PDZ-GEF1 phenocopies JAM-A loss with enhanced paracellular permeability.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, paracellular permeability assay, RhoA/myosin phosphorylation western blot\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP establishing complex, siRNA functional validation with defined permeability phenotype, multiple methods\",\n      \"pmids\": [\"23885123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RAPGEF2 is phosphorylated by IKKβ and CK1α in response to pro-migratory factors, leading to proteasomal degradation via the SCF(βTrCP) ubiquitin ligase. Failure to degrade RAPGEF2 sustains Rap1 activity and inhibits HGF-induced cell migration and breast cancer metastasis.\",\n      \"method\": \"In vivo phosphorylation assay, kinase inhibitor studies, ubiquitin ligase genetic manipulation, degradation-resistant RAPGEF2 mutant expression, Rap1-GTP pulldown, cell migration assay, in vivo metastasis assay\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — identified writer kinases (IKKβ, CK1α) and E3 ligase (SCF-βTrCP), with phospho-mutant functional rescue and in vivo metastasis validation, multiple orthogonal methods\",\n      \"pmids\": [\"24290981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RapGEF2 is phosphorylated by Cdk5, and this phosphorylation is required for RapGEF2-mediated Rap1 activation and N-cadherin upregulation during the multipolar-to-bipolar transition of cortical neurons. In utero electroporation knockdown of RapGEF2 blocks this polarity transition and radial migration.\",\n      \"method\": \"In utero electroporation, live imaging, Cdk5 kinase assay, Rap1-GTP pulldown, N-cadherin immunostaining, dominant-negative/constitutively active constructs\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — identified Cdk5 as the upstream kinase with functional epistasis through Rap1/N-cadherin pathway, loss-of-function with live imaging, multiple orthogonal methods\",\n      \"pmids\": [\"25189171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Rapgef2 (and Rapgef6) act cell-autonomously through Rap1 to maintain apical adherens junctions in radial glia. Double knockout of Rapgef2 and Rapgef6 disrupts apical AJ structures, detaches radial glial cells, and disorganizes the radial glial fiber system; constitutively active Rap1(G12V) rescues the AJ disruption, placing Rapgef2/6 upstream of Rap1 in this pathway.\",\n      \"method\": \"Conditional knockout mice, intrauterine Cre electroporation, constitutively active Rap1 rescue, immunostaining for AJ markers (β-catenin, N-cadherin), cortical layer analysis\",\n      \"journal\": \"eNeuro\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis confirmed by Rap1 rescue, double KO phenotypic analysis, cell-autonomous mechanism established by electroporation\",\n      \"pmids\": [\"27390776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NCS-Rapgef2 contains a cyclic nucleotide-binding domain (CNBD) that is required for cAMP-dependent ERK activation; mutation of a conserved CNBD residue abrogates cAMP-ERK coupling, whereas deletion of the CNBD results in constitutive ERK activation. NCS-Rapgef2 is encoded from an alternative first exon (exon 1') and is selectively expressed in neuronal and endocrine tissues.\",\n      \"method\": \"CNBD point mutagenesis and deletion mutagenesis, reconstitution in HEK293T cells, cAMP-ERK phosphorylation assay, tissue-specific mRNA and protein expression analysis, Rapgef2 CamK2α-Cre conditional KO mice, D1 receptor agonist ERK assay\",\n      \"journal\": \"eNeuro\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — active site mutagenesis plus conditional genetic KO plus reconstitution in non-expressing cells, replicated across multiple systems\",\n      \"pmids\": [\"28948210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The cAMP-binding pharmacophore of NCS-Rapgef2 is distinct from those of PKA and Epac. N6-Phe-cAMP is a selective NCS-Rapgef2 agonist, and N6-phenyl-9-tetrahydrofuranyladenine is a selective NCS-Rapgef2 inhibitor without activity at PKA, Epac, or adenylate cyclase.\",\n      \"method\": \"Cell-based pharmacological assay (high-content microscopy for ERK/PKA-II activation), EC50/IC50 determination for adenine derivatives across cAMP effectors in NS-1 neuroendocrine cells\",\n      \"journal\": \"ACS chemical neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based selectivity profiling with quantitative dose-response, single lab, no in vitro binding confirmation\",\n      \"pmids\": [\"28290664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RAPGEF2 forms a complex with MAGI2, and this interaction is lost when MAGI2 carries congenital nephrotic syndrome (CNS) variants. Co-expression of RapGEF2 with wild-type but not mutant MAGI2 enhances Rap1 activation in podocytes. Podocyte-specific RapGEF2 deletion in mice causes spontaneous glomerulosclerosis comparable to MAGI2 KO.\",\n      \"method\": \"Co-immunoprecipitation (MAGI2-RapGEF2 complex), Rap1-GTP pulldown, podocyte-specific conditional KO mice, siRNA knockdown in human podocytes, pharmacological Rap1 activation rescue\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, conditional KO phenotype, Rap1 activation measurement, rescue by Rap1 agonist, multiple orthogonal methods\",\n      \"pmids\": [\"31171376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NCS-Rapgef2 in nucleus accumbens D1-medium spiny neurons mediates cocaine-induced ERK phosphorylation and Egr-1/Zif268 upregulation via a D1 receptor→cAMP→NCS-Rapgef2→Rap1→B-Raf→MEK→ERK pathway. AAV-Cre-mediated NCS-Rapgef2 deletion in NAc eliminates cocaine-induced locomotor sensitization and conditioned place preference without affecting PKA/CREB phosphorylation.\",\n      \"method\": \"AAV-Synapsin-Cre injection for region-specific gene deletion, CamK2α-Cre conditional KO, pERK and Egr-1 immunostaining, cocaine behavioral tests (locomotor sensitization, CPP), ex vivo slice electrophysiology\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — region-specific genetic ablation with molecular (pERK, Egr-1) and behavioral readouts, pathway dissection from PKA/CREB, multiple brain regions and methods\",\n      \"pmids\": [\"33268547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In sensory neurons, cAMP-to-ERK signaling involves RapGEF2 (and PKA) but not Epac; Oncostatin M (OSM) priming enhances and prolongs this RapGEF2/PKA-dependent cAMP-ERK coupling in IB4/CaMKIIα-positive nociceptors.\",\n      \"method\": \"High-content microscopy for endogenous PKA-II and ERK activation, selective pharmacological inhibition of Rapgef2/Epac/PKA, OSM priming paradigm in primary sensory neuron cultures\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway dissection with quantitative single-cell readouts, single lab\",\n      \"pmids\": [\"32885411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RAPGEF2 upregulation mediates oligomeric Aβ-induced synaptic loss via activation of downstream Rap2 and JNK. siRNA silencing of RAPGEF2 blocks Aβ oligomer-induced dendritic spine loss in hippocampal neurons, and in vivo knockdown prevents cognitive deficits and excitatory synapse loss in 3xTg-AD mice.\",\n      \"method\": \"siRNA knockdown in primary hippocampal neurons, in vivo AAV-shRNA knockdown in 3xTg-AD mice, dendritic spine counting, Rap2/JNK activation western blot, behavioral testing (cognitive function), electron microscopy of synapses\",\n      \"journal\": \"Neuropathology and applied neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with defined molecular pathway (Rap2/JNK) and behavioral/synaptic readouts, multiple orthogonal methods\",\n      \"pmids\": [\"33345400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GLP-1 receptor stimulation activates ERK via NCS-RapGEF2 in pancreatic beta cells (INS-1) and NS-1 neuroendocrine cells; shRNA-mediated RapGEF2 knockdown reduces exendin-4-induced ERK phosphorylation, establishing NCS-RapGEF2 as a component of the GLP-1R→cAMP→ERK pathway.\",\n      \"method\": \"shRNA knockdown, pERK western blot, MEK inhibitor (U0126), transduction of GLP1R into NS-1 cells, neurite outgrowth assay, transcriptome analysis of INS-1 cells\",\n      \"journal\": \"Journal of neuroendocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined ERK readout, MEK dependency confirmed, single lab\",\n      \"pmids\": [\"33960038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RapGEF2 is required for cAMP-dependent ERK activation and Egr1 (but not c-Fos) induction in hippocampal CA1/dentate gyrus during fear conditioning, and for cAMP-dependent long-term potentiation at perforant pathway and Schaffer collateral synapses. Context-dependent fear memory is impaired by hippocampal RapGEF2 ablation.\",\n      \"method\": \"CamK2α-Cre conditional KO mice, pERK and Egr1 immunostaining after fear conditioning, LTP recording in hippocampal slices ex vivo, behavioral fear conditioning assay\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with molecular (pERK, Egr1), electrophysiological (LTP), and behavioral readouts, multiple orthogonal methods, gene-specific cre line\",\n      \"pmids\": [\"38236296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"RAPGEF2 operates downstream of the G13 (GNA13)-coupled receptors (αIIbβ3 integrin, thromboxane receptor) in platelets to activate RAP1 and mediate integrin αIIbβ3-dependent platelet adhesion under shear stress. Megakaryocyte-specific RAPGEF2 knockout reduces RAP1 activation and integrin activation, especially under elevated shear stress conditions.\",\n      \"method\": \"Megakaryocyte-specific conditional KO mice (Rapgef2mKO), double KO with CalDAG-GEFI, RAP1-GTP pulldown, platelet aggregation assay, microfluidic adhesion under shear stress, flow cytometry for integrin activation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO (single and double with CalDAG-GEFI) plus multiple platelet functional assays and RAP1 activation measurement, pathway epistasis established\",\n      \"pmids\": [\"41949994\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RAPGEF2 (PDZ-GEF1/NCS-Rapgef2/RA-GEF-2) is a ubiquitously expressed but neuronal/endocrine-enriched (NCS isoform) guanine nucleotide exchange factor that directly activates Rap1 and Rap2 GTPases; it is regulated by a cAMP-binding domain (acting as a negative regulator that cAMP can relieve), a positive-feedback RA domain that binds GTP-Rap1, upstream kinases (Cdk5 and IKKβ/CK1α—the latter targeting RAPGEF2 for SCF-βTrCP-mediated proteasomal degradation), and recruitment by activated M-Ras or scaffold complexes (S-SCAM/ARMS with TrkA at late endosomes; MAGI2 in podocytes; JAM-A/ZO-2/afadin at tight junctions; G13-coupled receptors in platelets); activated RAPGEF2 drives Rap1→B-Raf→MEK→ERK signaling underlying neurite outgrowth, neuronal migration (multipolar-bipolar transition via N-cadherin), synaptic plasticity and fear memory (ERK/Egr1), cocaine-induced behavioral sensitization, epithelial barrier maintenance, vascular morphogenesis, embryonic hematopoiesis, podocyte cytoskeletal integrity, and platelet adhesion.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RAPGEF2 (PDZ-GEF1/RA-GEF-2/NCS-Rapgef2) is a guanine nucleotide exchange factor that directly catalyzes nucleotide exchange on the small GTPases Rap1 and Rap2 — but not Ras — converting diverse upstream signals into Rap-dependent control of cell adhesion, junction integrity, migration, and ERK-driven gene expression [#0, #1]. Its catalytic output is tuned by intramolecular and recruitment-based regulation: a cyclic nucleotide-binding domain that, unlike Epac, couples cAMP to activation rather than acting as a classical cAMP sensor, while a Ras-association (RA) domain binds GTP-Rap1 to drive a positive-feedback loop and binds GTP-loaded M-Ras to recruit the enzyme to membranes and amplify Rap1 activation at the plasma membrane and perinuclear/Golgi compartment [#2, #1, #14]. A neuronal/endocrine-enriched isoform, NCS-Rapgef2, arises from an alternative first exon and links GPCR-driven cAMP elevation to a Rap1→B-Raf→MEK→ERK cascade in neurons and endocrine cells, where mutation of a conserved CNBD residue uncouples cAMP from ERK while CNBD deletion renders the enzyme constitutively active [#9, #14]. Through this Rap1-ERK axis NCS-Rapgef2 mediates cAMP-dependent neuritogenesis, fear-memory-associated Egr1 induction and hippocampal LTP, and cocaine-induced behavioral sensitization downstream of D1 receptors [#9, #21, #17]. RAPGEF2 is also assembled into membrane and junctional scaffolds — an S-SCAM/ARMS complex with the TrkA receptor at late endosomes that sustains NGF-induced Rap1/ERK signaling and neurite outgrowth, a JAM-A/ZO-2/afadin complex regulating epithelial tight-junction barrier function via Rap2, and a MAGI2 complex in podocytes maintaining glomerular integrity [#3, #10, #16]. Genetic studies establish broad in vivo roles in yolk-sac vascular morphogenesis and embryonic hematopoiesis, cortical neuronal migration and adherens-junction maintenance in radial glia, podocyte integrity, and G13-coupled integrin activation in platelets, all converging on Rap1 as confirmed by constitutively active Rap1 rescue [#5, #8, #7, #13, #16, #22]. RAPGEF2 stability is controlled by IKKβ/CK1α phosphorylation triggering SCF-βTrCP-mediated proteasomal degradation, which limits Rap1 activity to permit cell migration [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established RAPGEF2's core catalytic identity — that it is a GEF selective for Rap1 and Rap2 carrying a cAMP-binding-like domain that, unlike Epac, does not bind cyclic nucleotides.\",\n      \"evidence\": \"In vitro and in vivo GEF assays with domain deletion mutagenesis and cAMP/cGMP binding tests\",\n      \"pmids\": [\"10608883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the cAMP-binding-like domain regulates activity if it does not bind cAMP was unresolved\", \"No upstream activating signal identified at this stage\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined the RA domain as a dual regulatory module — binding GTP-M-Ras to recruit RAPGEF2 to the plasma membrane and binding GTP-Rap1 to create a positive-feedback amplification loop at perinuclear/Golgi membranes.\",\n      \"evidence\": \"GST pulldown binding-specificity panels, RA-domain deletion, Rap1/B-Raf activation assays and co-localization in COS-7 cells\",\n      \"pmids\": [\"11524421\", \"11359771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological receptors triggering M-Ras activation not defined\", \"In vivo significance of the feedback loop not yet tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected RAPGEF2 to receptor signaling and immune adhesion by placing it in a TrkA/S-SCAM/ARMS late-endosomal complex for NGF-induced neurite outgrowth and in an M-Ras→Rap1 pathway for TNF-α-induced LFA-1 activation.\",\n      \"evidence\": \"Reciprocal Co-IP, endosomal fractionation and live imaging with neurite readout; siRNA and knockout-mouse splenocyte aggregation assays\",\n      \"pmids\": [\"17724123\", \"17538012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and assembly order of the tetrameric TrkA complex not resolved\", \"Whether the same recruitment logic applies across cell types not addressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated an essential developmental requirement by showing RAPGEF2 knockout causes mid-gestation lethality with failed yolk-sac vascular plexus formation.\",\n      \"evidence\": \"Conventional knockout mice with embryo morphology and histology\",\n      \"pmids\": [\"17826737\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular effector linking RAPGEF2 loss to vascular failure not yet defined\", \"Single-lab observation\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Placed RAPGEF2 mechanistically upstream of Rap1 in vascular morphogenesis, showing it is needed for VE-cadherin junctional accumulation and that constitutively active Rap1 rescues the defect.\",\n      \"evidence\": \"Allantois explant culture, Rap1 activation probe, VE-cadherin staining and CA-Rap1 rescue\",\n      \"pmids\": [\"19635461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor input driving RAPGEF2 in endothelium not identified\", \"How Rap1 controls VE-cadherin localization not detailed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed a CNS requirement, showing dorsal-telencephalon RAPGEF2 deletion causes cortical migration defects (band heterotopia), commissural agenesis, and lowered seizure threshold.\",\n      \"evidence\": \"Emx1-Cre conditional knockout with histology, retrograde tracing and EEG seizure measurement\",\n      \"pmids\": [\"19453629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular mechanism of the migration defect not resolved at this stage\", \"Downstream Rap1 effectors in neurons not yet defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined RAPGEF2's role in embryonic hematopoiesis, linking its loss to impaired Rap1/B-Raf/ERK signaling and reduced Scl/Gata transcription factor expression, while showing adult hematopoiesis is independent.\",\n      \"evidence\": \"Conditional knockout mice, flow cytometry, colony assays, Rap1-GTP pulldown, ERK/B-Raf Western and RT-PCR\",\n      \"pmids\": [\"20595512\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct link between ERK signaling and Scl/Gata transcription not mechanistically dissected\", \"Why the requirement is embryo-restricted is unexplained\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established the long-sought cAMP-to-ERK function — that Rapgef2 couples GPCR cAMP elevation to Rap1→B-Raf→MEK→ERK and is directly enriched by cAMP affinity, plus defined its roles in tight-junction barrier function (via Rap2/JAM-A/ZO-2/afadin) and as a degradation target of IKKβ/CK1α/SCF-βTrCP controlling migration.\",\n      \"evidence\": \"cAMP-agarose affinity chromatography with loss/gain-of-function ERK readouts; reciprocal Co-IP with permeability assays; phospho-mutant rescue with metastasis assay\",\n      \"pmids\": [\"23800469\", \"23885123\", \"24290981\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cAMP binds RAPGEF2 directly or via a partner was not structurally resolved\", \"Phospho-degron site geometry on RAPGEF2 not mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified Cdk5 as an upstream activating kinase, showing its phosphorylation of RapGEF2 is required for Rap1-driven N-cadherin upregulation in the cortical multipolar-to-bipolar transition.\",\n      \"evidence\": \"In utero electroporation, live imaging, Cdk5 kinase assay, Rap1 pulldown and N-cadherin staining\",\n      \"pmids\": [\"25189171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cdk5 phosphosite(s) on RapGEF2 not mapped\", \"Mechanism linking Rap1 to N-cadherin transcription/trafficking not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed RapGEF2 (with Rapgef6) maintains apical adherens junctions in radial glia cell-autonomously through Rap1, confirmed by CA-Rap1 rescue of the double-knockout phenotype.\",\n      \"evidence\": \"Conditional double knockout, Cre electroporation, CA-Rap1 rescue and adherens-junction marker immunostaining\",\n      \"pmids\": [\"27390776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional redundancy boundaries between RAPGEF2 and RAPGEF6 not delineated\", \"Effector connecting Rap1 to AJ stability not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved the structural basis of cAMP coupling, defining the NCS-Rapgef2 CNBD as required for cAMP-dependent ERK activation and identifying the tissue-restricted exon-1' isoform plus a distinct cAMP pharmacophore with selective agonists/inhibitors.\",\n      \"evidence\": \"CNBD point and deletion mutagenesis with reconstitution and conditional KO; cell-based pharmacological selectivity profiling of adenine derivatives\",\n      \"pmids\": [\"28948210\", \"28290664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct in vitro cAMP binding to the CNBD not biochemically confirmed\", \"Structural mechanism of how CNBD occupancy relieves autoinhibition not solved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Tied RAPGEF2 to podocyte biology and disease, showing it forms a Rap1-activating complex with MAGI2 disrupted by congenital nephrotic syndrome variants, with podocyte-specific deletion causing glomerulosclerosis.\",\n      \"evidence\": \"Co-IP, Rap1-GTP pulldown, podocyte conditional KO, siRNA in human podocytes and Rap1-agonist rescue\",\n      \"pmids\": [\"31171376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RAPGEF2 mutations themselves cause human nephrotic syndrome not established\", \"Cytoskeletal effector downstream of podocyte Rap1 not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established NCS-Rapgef2 as the cAMP-ERK node for reward and nociceptive signaling, mediating D1-receptor-driven cocaine sensitization (independent of PKA/CREB) and OSM-primed sensory-neuron cAMP-ERK coupling.\",\n      \"evidence\": \"Region-specific AAV-Cre ablation with pERK/Egr-1 readouts and cocaine behavioral assays; pharmacological pathway dissection in sensory neurons\",\n      \"pmids\": [\"33268547\", \"32885411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NCS-Rapgef2-ERK signaling drives synaptic plasticity changes underlying sensitization not fully detailed\", \"Sensory-neuron data rest on pharmacology, not genetics\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Broadened the disease and endocrine relevance of RAPGEF2, implicating it in Aβ-induced synaptic loss via Rap2/JNK and in GLP-1 receptor→ERK signaling in beta cells.\",\n      \"evidence\": \"siRNA and in vivo AAV-shRNA knockdown in 3xTg-AD mice with spine/behavior readouts; shRNA knockdown with pERK and MEK-inhibitor analysis in INS-1/NS-1 cells\",\n      \"pmids\": [\"33345400\", \"33960038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Aβ upregulates RAPGEF2 mechanistically not defined\", \"Switch between Rap1-ERK and Rap2-JNK output not explained\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrated RapGEF2's role in hippocampal memory, showing it is required for cAMP-dependent ERK/Egr1 induction and LTP during fear conditioning, with selectivity for Egr1 over c-Fos.\",\n      \"evidence\": \"CamK2α-Cre conditional KO with pERK/Egr1 immunostaining, ex vivo LTP recording and fear-conditioning behavior\",\n      \"pmids\": [\"38236296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Basis of the Egr1-versus-c-Fos selectivity not resolved\", \"Synaptic locus of RapGEF2 action not pinpointed\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Extended RAPGEF2 function to hemostasis, placing it downstream of G13-coupled receptors to drive Rap1 and integrin αIIbβ3 activation for shear-dependent platelet adhesion, distinct from CalDAG-GEFI.\",\n      \"evidence\": \"Megakaryocyte-specific KO and double KO with CalDAG-GEFI, RAP1 pulldown, microfluidic shear adhesion and flow cytometry\",\n      \"pmids\": [\"41949994\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct link between G13/GNA13 and RAPGEF2 recruitment not biochemically resolved\", \"How shear stress selectively engages the RAPGEF2 arm not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single GEF integrates its multiple regulatory inputs (cAMP/CNBD, RA-domain feedback, Cdk5 and IKKβ/CK1α phosphorylation, scaffold recruitment) into context-specific Rap1 versus Rap2 output remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model integrating CNBD, RA-domain and catalytic GEF domains\", \"Determinants selecting Rap1-ERK versus Rap2-JNK signaling unknown\", \"Whether cAMP binds the CNBD directly not biochemically confirmed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3, 10, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 14, 17]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 7, 8, 13]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 17, 21]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [22]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [10, 16]}\n    ],\n    \"complexes\": [\n      \"S-SCAM/ARMS/TrkA complex\",\n      \"JAM-A/ZO-2/afadin complex\"\n    ],\n    \"partners\": [\n      \"RAP1\",\n      \"RAP2\",\n      \"MRAS\",\n      \"TrkA\",\n      \"MAGI2\",\n      \"JAMA\",\n      \"CDK5\",\n      \"GNA13\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}